Notably, KLF9 contributes to cancer development in other malignancies, such as pancreatic cancer (54–56), prostate cancer (57), thyroid cancer (58–60), and bladder cancer (61–63). The gene discussed is KLF9; the disease is pancreatic neoplasm.